AxSpA Boot Camp: Are You Up to Date on Recent Advances?

Target Audience 

The activity is directed toward specialist rheumatology care clinicians, nurse practitioners, and physician associates who provide diagnostic and therapeutic services for patients with or at risk of axial spondyloarthritis (AxSpA) as well as nonspecialists and primary care providers who care for patients with AxSpA. 

Program Overview 

With a multitude of possible clinical presentations and a lack of validated diagnostic criteria, late or missed diagnosis of AxSpA is all too common in clinical practice. Further complicating diagnosis, a subset of patients with AxSpA do not exhibit radiographic changes on plain film x-ray. With recent advances in the therapeutic armamentarium able to halt the irreversible structural changes associated with AxSpA progression, it is more important than ever to diagnose AxSpA as early as possible. Therefore, best practices for early recognition and diagnosis, as well as implementation biologic and small molecule therapies, are valuable to improve outcomes in this patient population. AxSpA Boot Camp: Are You Up to Date on Recent Advances? is a multimedia training program designed to strengthen expertise in the diagnosis and management of AxSpA. 

Educational Objectives  

After completing this activity, the participant should be better able to: 

• Describe the diagnostic procedures for both ankylosing spondylitis (AS) and nr-AxSpA
• Identify the mechanisms of action, relative benefits, and safety profiles of current biologic and small-molecule therapies for AS and/or non-radiographic (nr)-AxSpA
• Incorporate clinical strategies for individualized selection of AxSpA therapy with consideration of patient preference and the presence of any extra-musculoskeletal manifestations and/or comorbid conditions 

Physician Accreditation Statement 

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

Physician Credit Designation 

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse Practitioner Continuing Education 

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.2 hour(s) of pharmacology). 

Global Contact Information 

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com. 

Instructions to Receive Credit 

To receive credit for this activity, participants must complete the preactivity questionnaire, complete and receive a minimum score of 70% on the posttest, and complete the program evaluation. 

Fee Information & Refund/Cancellation Policy 

There is no fee for this educational activity. 

Disclosures of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.  

The faculty have the following relevant financial relationships with ineligible companies:

Alexis R. Ogdie, MD, MSCE - Consultant: AbbVie Inc.; Amgen, Inc.; Brostol-Myers Squibb; Celgene Corporation; CorEvitas; Eli Lilly; Gilead Sciences, Inc.; Janssen; Kopa; Novartis Pharmaceuticals; Pfizer Inc.; UCB

Contracted Research: AbbVie Inc. (paid to Penn), Amgen (paid to Forward NDB), Novartis Pharmacueticals (paid directly to Penn), Pfizer Inc. (paid to Penn)

The planners and managers from Global Education Group and Integritas Communications have no relevant financial relationships with ineligible companies to disclose.